These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 2136911)

  • 1. Detection of membrane-bound and soluble antigens by magnetic levitation.
    Andersen MS; Howard E; Lu S; Richard M; Gregory M; Ogembo G; Mazor O; Gorelik P; Shapiro NI; Sharda AV; Ghiran I
    Lab Chip; 2017 Oct; 17(20):3462-3473. PubMed ID: 28905952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis.
    Singh A; Vastert SJ; Prakken BJ; Illges H
    Rheumatol Int; 2012 Jun; 32(6):1581-7. PubMed ID: 21328056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease.
    Masilamani M; Rajasekaran N; Singh A; Low HZ; Albus K; Anders S; Behne F; Eiermann P; König K; Mindnich C; Ribarska T; Illges H
    Rheumatol Int; 2008 Sep; 28(11):1137-41. PubMed ID: 18500464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV induces modulation of functionally important cellular antigens.
    Wrightham M; Schimpf A; Pennington TH; Walker F; Sewell HF
    Clin Exp Immunol; 1991 Jul; 85(1):75-9. PubMed ID: 1712685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge.
    Johnson PR; Montefiori DC; Goldstein S; Hamm TE; Zhou J; Kitov S; Haigwood NL; Misher L; London WT; Gerin JL
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2175-9. PubMed ID: 1549578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
    Ahearn JM; Fearon DT
    Adv Immunol; 1989; 46():183-219. PubMed ID: 2551147
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV.
    Delibrias CC; Kazatchkine MD; Fischer E
    Scand J Immunol; 1993 Aug; 38(2):183-9. PubMed ID: 8346417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons.
    June RA; Landay AL; Stefanik K; Lint TF; Spear GT
    Immunology; 1992 Jan; 75(1):59-65. PubMed ID: 1371493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.
    Cohen JH; Fischer E; Kazatchkine MD; Lenoir GM; Lefevre-Delvincourt C; Revillard JP
    Scand J Immunol; 1987 Jun; 25(6):587-98. PubMed ID: 3037684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation of resting B cells is modulated by CR2 and CR1.
    Fingeroth JD; Heath ME; Ambrosino DM
    Immunol Lett; 1989 Jun; 21(4):291-301. PubMed ID: 2527816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the C3d/EBV receptor and of other cell membrane surface markers is altered upon HIV-1 infection of myeloid, T, and B cells.
    Larcher C; Schulz TF; Hofbauer J; Hengster P; Romani N; Wachter H; Dierich MP
    J Acquir Immune Defic Syndr (1988); 1990; 3(2):103-8. PubMed ID: 2136911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement receptor type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21).
    Fearon DT; Ahearn JM
    Curr Top Microbiol Immunol; 1990; 153():83-98. PubMed ID: 2153507
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.